Exosome Therapy for Livedoid Vasculitis Following COVID-19 Vaccination: A Case Report
Drug, Healthcare and Patient Safety · 2026-05 · Volume 18 · 1-5
DOI: 10.2147/dhps.s596013 ↗Kurz gefasst
Fallbericht in der Zeitschrift Drug, Healthcare and Patient Safety, 2026-05. Verfasst von Tsung-Kun Lin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Tri-Service General Hospital, Taipei, Taiwan, Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Tri-Service General Hospital, Taipei, Taiwan, Republic of China.
- School of Pharmacy, National Defense Medical University, Taipei, Taiwan, Republic of China.
- Division of Cardiology, Department of Internal Medicine, Taichung Armed Force General Hospital, Taichung, Taiwan, Republic of China.
- Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan, Republic of China.
- School of Medicine, Chung Shan Medical University, Taichung, Taiwan, Republic of China.
ORCID-Profile: Gwo-Ping Jong
Zitieren
APA
Lin, T. K., Chang, C. F., & Jong, G. P. (2026). Exosome Therapy for Livedoid Vasculitis Following COVID-19 Vaccination: A Case Report. Drug, Healthcare and Patient Safety, Volume 18, 1-5. https://doi.org/10.2147/dhps.s596013
Vancouver
Lin TK, Chang CF, Jong GP. Exosome Therapy for Livedoid Vasculitis Following COVID-19 Vaccination: A Case Report. Drug, Healthcare and Patient Safety. 2026;Volume 18:1-5. doi:10.2147/dhps.s596013
BibTeX
@article{Lin2026,
author = {Lin, Tsung-Kun and Chang, Chih-Feng and Jong, Gwo-Ping},
title = {Exosome Therapy for Livedoid Vasculitis Following COVID-19 Vaccination: A Case Report},
journal = {Drug, Healthcare and Patient Safety},
year = {2026},
volume = {Volume 18},
pages = {1--5},
doi = {10.2147/dhps.s596013}
}
EUVIMED